Page last updated: 2024-08-22

tiletamine hydrochloride and Genetic Diseases

tiletamine hydrochloride has been researched along with Genetic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Dhalimy, M; Finegold, M; Grompe, M; Manning, K; Ou, CN; Overturf, K1
de Kremer Dodelson, R; Depetris-Boldini, C; Galetto, R; Videla, MP1

Other Studies

2 other study(ies) available for tiletamine hydrochloride and Genetic Diseases

ArticleYear
Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
    Human gene therapy, 1998, Feb-10, Volume: 9, Issue:3

    Topics: Amino Acid Metabolism, Inborn Errors; Animals; Base Sequence; Cell Survival; Cell Transplantation; Cells, Cultured; Cyclohexanones; Disease Models, Animal; DNA, Complementary; Enzyme Inhibitors; Female; Genetic Diseases, Inborn; Genetic Therapy; Humans; Hydrolases; Liver; Male; Mice; Molecular Sequence Data; Nitrobenzoates; Tyrosine

1998
Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: relevant changes with NTBC treatment.
    Journal of inherited metabolic disease, 1999, Volume: 22, Issue:3

    Topics: Amino Acid Metabolism, Inborn Errors; Child; Coproporphyrins; Cyclohexanones; Enzyme Inhibitors; Female; Genetic Diseases, Inborn; Humans; Hydrolases; Nitrobenzoates; Tyrosine

1999